Physician profile
Kyra Blatt
NPI 1366520314
$15,014.84
in general payments reported to CMS, 2019-2025
50 companies · $940 in 2025
The $940 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $163 · 2020: $640 · 2021: $2,342 · 2022: $8,436 · 2023: $1,330 · 2024: $1,164 · 2025: $940.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,355 · Education: $79.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,355.02 |
| Education | $79.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $6,961.74 | 2020-2025 | Emgality, Amyvid, Kisunla |
| Abbvie INC. | $1,880.40 | 2021-2025 | Qulipta, Ubrelvy, Botox |
| Teva Pharmaceuticals USA, INC. | $825.62 | 2019-2024 | Austedo Xr |
| Acadia Pharmaceuticals INC | $537.89 | 2021-2025 | Nuplazid |
| Allergan, INC. | $449.21 | 2020-2022 | |
| Biohaven Pharmaceuticals, INC. | $394.56 | 2020-2021 | |
| Pfizer INC. | $318.98 | 2019-2025 | |
| Amgen INC. | $312.57 | 2020-2024 | Uplizna |
| Horizon Therapeutics Plc | $271.78 | 2022-2023 | Uplizna |
| Biogen, INC. | $252.18 | 2020-2025 | Tysabri |
| Lundbeck LLC | $248.04 | 2020-2025 | Vyepti |
| Neurocrine Biosciences, INC. | $218.62 | 2021-2024 | Ingrezza, Ongentys |
| Boston Scientific Corporation | $176.43 | 2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $164.05 | 2022 | |
| Upsher-Smith Laboratories LLC | $161.39 | 2020-2022 |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyra Blatt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.